Ligases Enzyme Market, by Source (Micro-organism, Animal, Plant), by Application (Polymerase Chain Reaction, Cloning, Mutation Detection, Next Generation Sequencing, Drug Target) and, by End User (Diagnostic Center Hospital, Research Institute): Global Opportunity Analysis and Industry Forecast, 2023-2032

Enzymes are biological catalysts that accelerate the speed of chemical reactions, especially the ones that occur within the body of an organism. Ligases are a specific type of enzymes that speed up the joining of two large molecules such as DNA. These enzymes are extensively used in cloning, mutation detection, gene synthesis, and next generation sequencing. Ligases enzymes are also used for correcting dysfunctions and lack of DNA ligases in humans.

The ligases enzymes market exhibits growth, due to increase in research activities and R&D investments to develop ligases as targets for therapeutic intervention of cancer. Furthermore, increase in incidence of birth genetic disorders, and infectious diseases is expected to drive the market growth as ligases find application in detection birth mutations, and infectious diseases. This market is restricted by handling and safety issues related to enzymes and constraints pertaining to the chemical and physical properties of enzymes. The involvement of enzymes in protein engineering and growth opportunities in developing regions such as Asia-Pacific and LAMEA are projected to make way for different market growth opportunities.

The ligases enzymes market is segmented based on source, application, end user, and region. By source, it is divided into micro-organism, animal, and plant. By application, it is classified into polymerase chain reaction, cloning, mutation detection, next generation sequencing, and drug targets. By end user, the market is bifurcated into diagnostic center & hospital, and research institute. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), Asia-Pacific (Japan, China, Singapore, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

The key players operating in this industry include Novozymes A/S, Koninklijke DSM N.V., DowDuPont Inc., BASF SE, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis, Inc., Amano Enzyme, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc.

Key Benefits

• The report provides a quantitative analysis of the current market and estimation that assists in identifying the current market opportunities.
• The report contains a thorough analysis of the factors that drive and restrict the growth of the global ligases enzymes market.
• The projections in the report are made by analyzing the current and future market trends for a period.
• Comprehensive analysis of the geographic regions is provided, which helps elucidate region wise growth.
• Key market players within the ligases enzyme market are profiled to understand the competitor scenario.

  Ligases Enzyme Market, by Source Report Highlights

Aspects	Details
By Source	Micro-organism Animal Plant
By Application	Polymerase Chain Reaction Cloning Mutation Detection Next Generation Sequencing Drug Target
By End User	Diagnostic Center & Hospital Research Institute
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Codexis, Inc., AB Enzymes GmbH, Koninklijke DSM N.V., Amano Enzyme, DowDuPont Inc., BASF SE, Novozymes A/S, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Advanced Enzyme Technologies Ltd.

^*Terms and Conditions Apply